PHARMACOLOGIC PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM: THE MOST FREQUENT REASON FOR OMITTING ORDERED DOSES IS PATIENT REFUSAL von Fanikos, John, Stevens, Leslie-Ann, Piazza, Gregory, Labreche, Mathew, Catapane, Elaine, Novack, Lena, Goldhaber, Samuel Z

Volltext

FONDAPARINUX USE AT A MAJOR ACADEMIC MEDICAL CENTER von Baroletti, Steven A., Labreche, Mathew, Niles, Mathew, Fanikos, John, Goldhaber, Samuel Z.

Volltext

HEPARIN INDUCED THROMBOCYTOPENIA: CLINICAL AND ECONOMIC OUTCOMES von Baroletti, Steven A., Piovella, Chiara, Fanikos, John, Labreche, Mathew, Lin, Jay, Goldhaber, Samuel Z.

Volltext